Skip to main content
Premium Trial:

Request an Annual Quote

Japanese Red Cross to Use Roche Nucleic Acid Tools to Scan Blood Supply for HIV, HBV, HCV

NEW YORK (GenomeWeb News) — The Japanese Red Cross will use Roche’s PCR-based testing devices to screen the nation’s supply of donated blood for HIV and hepatitis B and C, the company said today.
 
Roche said it will supply next-generation nucleic acid-screening products to accommodate Japan’s 5 million annual blood donations. The tools will comprise Roche’s Cobas 401 and its TaqScreen MPX test, which can detect HIV-1, HIV-2, and hepatitis B and C viruses.
 
The company said in 2008 the 401 and the TaqScreen MPX will replace its AmpliNAT multiplex test, which has been in "routine use” in three Japanese Red Cross testing centers since 1999.
 
Financial terms of the agreement were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.